Clinical Outcomes Sacral Neuromodulation
The InterStim Therapy for Bowel Control Prospective Clinical Study demonstrates a statistically significant decline in chronic fecal incontinence 12 months post implant.
VIEW STUDY RESULTSYour browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The InterStim Therapy for Bowel Control Prospective Clinical Study demonstrates a statistically significant decline in chronic fecal incontinence 12 months post implant.
VIEW STUDY RESULTSFrom the Medtronic Manual Library by searching for the product name or model number
GO TO THE LIBRARY